What Happened?
Lake Zurich, IL-based Fresenius Kabi Appointed Scott Van Etten as Director Regional Sales | Oncology Biosimilars | East Region
About the Company
Fresenius Kabi is a global health care company that specializes in lifesaving medicines and medical technologies for infusion, transfusion and clinical nutrition. Our expansive portfolio of products and global network of science and manufacturing centers provide essential support for the care of critical and chronically ill patients. We are part of Fresenius SE, a health care group with more than 100 years of experience in pharmaceuticals, medical devices and life sciences. Our employees – more than 35,000 worldwide – develop and deliver injectable pharmaceuticals and infusion systems; blood collection, transfusion and cell technologies; and essential nutrients for parenteral nutrition. We have special expertise in medicines for oncology, infection, anesthesia, analgesia and critical care. Our products are used in all sites of care – from hospitals and clinics to blood and plasma centers, and increasingly in patients’ homes. In biosimilars, we are developing products with a focus on oncology and autoimmune diseases.
About the Person
Scott Van Etten is Director Regional Sales | Oncology Biosimilars | East Region at Fresenius Kabi. Previously, Scott held various senior HR leadership roles in the industry.
Info Source
News
Short Profile